Stock Track | INSILICO Soars 5.19% Intraday on Upcoming AI Drug Research Presentation at AACR 2026

Stock Track04-22 10:19

INSILICO's stock surged 5.19% during the morning session, reflecting strong positive investor sentiment.

The sharp rise follows the company's announcement that it will present four generative AI-driven preclinical research findings, including results for ISM6166, at the upcoming 2026 American Association for Cancer Research (AACR) Annual Meeting. This marks the fourth consecutive year the biotech firm will showcase its research at the prestigious conference.

All selected studies focus on internally developed oncology drug candidates and will be featured in the poster presentation session. Notably, two of the projects were initiated by INSILICO's research and development center in the United Arab Emirates, highlighting the global reach of its AI-powered drug discovery platform.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1121328294?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-22 10:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121328294","market":"sg","top_or_hot":-1,"title":"Stock Track | INSILICO Soars 5.19% Intraday on Upcoming AI Drug Research Presentation at AACR 2026","media":"Stock Track","content":"<p>INSILICO's stock surged 5.19% during the morning session, reflecting strong positive investor sentiment.</p><p>The sharp rise follows the company's announcement that it will present four generative AI-driven preclinical research findings, including results for ISM6166, at the upcoming 2026 American Association for Cancer Research (AACR) Annual Meeting. This marks the fourth consecutive year the biotech firm will showcase its research at the prestigious conference.</p><p>All selected studies focus on internally developed oncology drug candidates and will be featured in the poster presentation session. Notably, two of the projects were initiated by INSILICO's research and development center in the United Arab Emirates, highlighting the global reach of its AI-powered drug discovery platform.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | INSILICO Soars 5.19% Intraday on Upcoming AI Drug Research Presentation at AACR 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | INSILICO Soars 5.19% Intraday on Upcoming AI Drug Research Presentation at AACR 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-22 10:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>INSILICO's stock surged 5.19% during the morning session, reflecting strong positive investor sentiment.</p><p>The sharp rise follows the company's announcement that it will present four generative AI-driven preclinical research findings, including results for ISM6166, at the upcoming 2026 American Association for Cancer Research (AACR) Annual Meeting. This marks the fourth consecutive year the biotech firm will showcase its research at the prestigious conference.</p><p>All selected studies focus on internally developed oncology drug candidates and will be featured in the poster presentation session. Notably, two of the projects were initiated by INSILICO's research and development center in the United Arab Emirates, highlighting the global reach of its AI-powered drug discovery platform.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1121328294","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121328294","pubTimestamp":1776824366,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"INSILICO's stock surged 5.19% during the morning session, reflecting strong positive investor sentiment.The sharp rise follows the company's announcement that it will present four generative...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"个股追踪|INSILICO盘中大涨5.19%即将在AACR 2026上发表AI药物研究演讲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"INSILICO's stock surged 5.19% during the morning session, reflecting strong positive investor sentiment.The sharp rise follows the company's announcement that it will present four generative AI-driven preclinical research findings, including results for ISM6166, at the upcoming 2026 American Association for Cancer Research (AACR) Annual Meeting. This marks the fourth consecutive year the biotech firm will showcase its research at the prestigious conference.All selected studies focus on internally developed oncology drug candidates and will be featured in the poster presentation session. Notably, two of the projects were initiated by INSILICO's research and development center in the United Arab Emirates, highlighting the global reach of its AI-powered drug discovery platform.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1121328294","isCrawlerRequest":true}